Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dynex to Market Binding Site's Workstation

By Labmedica staff writers
Posted on 17 Aug 2005
Under an expanded agreement, Dynex Technologies (Chelmsford, MA, USA) will market the DSX "walk-away” workstation of The Binding Site (Birmingham, UK).

The Binding Site will include in the workstation its full range of enzyme-linked immunosorbent assay (ELISA) kits and reagents, along with exclusive 24-hour service and support as part of a complete laboratory solution for the automation of autoimmune and infectious-disease assays.

Dynex Technologies is a leading manufacturer of microplate instrumentation incorporating advanced detection and automated sample handling, consumables, and accessories used in clinical diagnostics and biomedical research. More...


"We've very pleased to continue our long-term relationship with The Binding site as part of our strategy to partner with premier providers to expand the reach of our technologies and service clinical customers better,” stated Dr. Robert J. Rosenthal, CEO and president of Dynex. "We designed the DSX to be an open system so clinical laboratories can have the flexibility they need to run virtually any ELISA assay.”

The Binding Site specializes in the research, development, and production of immunodiagnostic kits and reagents for use in the investigation of diseases. The company has a global network of distributors.

"Now, through this expanded agreement we can better serve our customers with our entire range of autoimmune and infectious disease ELISA kits, and by providing the technical expertise to fully realize the potential of the DSX as an open-system platform,” commented Anne Grainger, vice president, sales and technical services.





Related Links:
Dynex
The Binding Site

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.